Science Translational Medicine
2 November 2011 vol 3, issue 107
http://stm.sciencemag.org/content/current
Focus – Virus-Associated Disease
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
Jeffrey I. Cohen, Anthony S. Fauci, Harold Varmus, and Gary J. Nabel
2 November 2011: 107fs7
Abstract
Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.